Antibody affinity and valency impact brain uptake of transferrin receptor-targeted gold nanoparticles.
Ontology highlight
ABSTRACT: Rationale: The ability to treat invalidating neurological diseases is impeded by the presence of the blood-brain barrier (BBB), which inhibits the transport of most blood-borne substances into the brain parenchyma. Targeting the transferrin receptor (TfR) on the surface of brain capillaries has been a popular strategy to give a preferential accumulation of drugs or nanomedicines, but several aspects of this targeting strategy remain elusive. Here we report that TfR-targeted gold nanoparticles (AuNPs) can accumulate in brain capillaries and further transport across the BBB to enter the brain parenchyma. Methods: We characterized our targeting strategy both in vitro using primary models of the BBB and in vivo using quantitative measurements of gold accumulation by inductively-c
SUBMITTER: Johnsen KB
PROVIDER: S-EPMC6010987 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA